Olaparib: as the comparator
2 studies: what is tested is compared with it. Page 1 of 1. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.
- Fluzoparib + Bevacizumab vs Olaparib + Bevacizumab for Maintenance Therapy in HRD-Positive Advanced Ovarian CancerNot yet recruitingNCT07647653Phase 2Report a problem
- A Randomized Secondary Adjuvant Treatment Intervention Study Comparing Trastuzumab-Deruxtecan to SOC Therapy in eBC Patients With Molecular RelapseRecruitingNCT06643585Phase 3Report a problem